Christopher Carlos, MD, MAS

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address500 Parnassus Avenue, #E412
San Francisco CA 94143
vCardDownload vCard

    Collapse Biography 
    Collapse Education and Training
    Stanford University, Stanford, CABA2007Human Biology
    Case Western Reserve University, Cleveland, OHMD2013School of Medicine
    UCSF, San Francisco, CAResidency2016Internal Medicine
    UCSF, San Francisco, CAFellowship2018Nephrology
    UCSF, San Francisco, CAMAS2019Clinical Research

    Collapse Overview 
    Collapse Overview
    Dr. Christopher Carlos is an Assistant Professor within the Division of Nephrology and a board-certified nephrologist. He practices both inpatient and outpatient nephrology. In his outpatient clinic, he specializes in treating patients with acute kidney injury, chronic kidney disease, end-stage kidney disease, hypertension, electrolyte imbalances and glomerular disorders.

    Dr. Carlos earned his medical degree from Case Western Reserve University School of Medicine. He completed his residency in Internal Medicine at UCSF, where he also completed a fellowship in Nephrology. During his fellowship, he obtained a Master's Degree in Clinical Research from the UCSF School of Epidemiology and Biostatistics. His primary research interest was in the effect of dialysis therapies on physical function and well-being.

    He is a member of the American Society of Nephrology and National Kidney Foundation.

    Collapse Research 
    Collapse Research Activities and Funding
    Dialysis Rx to Yield Optimal UltrafilTration (DRYOUT)
    NIH F32DK118829Jul 2, 2018 - Jul 1, 2020
    Role: Principal Investigator

    Collapse ORNG Applications 
    Collapse Clinical Trials
    Collapse Featured Publications

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Shorter versus longer corticosteroid duration and recurrent immune checkpoint inhibitor-associated AKI. J Immunother Cancer. 2022 09; 10(9). Gupta S, Garcia-Carro C, Prosek JM, Glezerman I, Herrmann SM, Garcia P, Abudayyeh A, Lumlertgul N, Malik AB, Loew S, Beckerman P, Renaghan AD, Carlos CA, Rashidi A, Mithani Z, Deshpande P, Rangarajan S, Shah CV, Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Ortiz-Melo DI, Sprangers B, Aggarwal V, Benesova K, Wanchoo R, Murakami N, Cortazar FB, Reynolds KL, Sise ME, Soler MJ, Leaf DE, ICPi-AKI Consortium Investigators. PMID: 36137651; PMCID: PMC9511654.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    2. Acute kidney injury in patients receiving pembrolizumab combination therapy versus pembrolizumab monotherapy for advanced lung cancer. Kidney Int. 2022 10; 102(4):930-935. Gupta S, Strohbehn IA, Wang Q, Hanna PE, Seethapathy R, Prosek JM, Herrmann SM, Abudayyeh A, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, de Seigneux S, Campedel L, Kitchlu A, Shin DS, Coppock G, Lumlertgul N, Garcia P, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Benesova K, Jhaveri KD, Cortazar FB, Weins A, Zuo Y, Mooradian MJ, Reynolds KL, Leaf DE, Sise ME, ICPi-AKI Consortium. PMID: 35964800; PMCID: PMC9523226.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    3. Acute kidney injury in patients treated with immune checkpoint inhibitors. J Immunother Cancer. 2021 10; 9(10). Gupta S, Short SAP, Sise ME, Prosek JM, Madhavan SM, Soler MJ, Ostermann M, Herrmann SM, Abudayyeh A, Anand S, Glezerman I, Motwani SS, Murakami N, Wanchoo R, Ortiz-Melo DI, Rashidi A, Sprangers B, Aggarwal V, Malik AB, Loew S, Carlos CA, Chang WT, Beckerman P, Mithani Z, Shah CV, Renaghan AD, Seigneux S, Campedel L, Kitchlu A, Shin DS, Rangarajan S, Deshpande P, Coppock G, Eijgelsheim M, Seethapathy H, Lee MD, Strohbehn IA, Owen DH, Husain M, Garcia-Carro C, Bermejo S, Lumlertgul N, Seylanova N, Flanders L, Isik B, Mamlouk O, Lin JS, Garcia P, Kaghazchi A, Khanin Y, Kansal SK, Wauters E, Chandra S, Schmidt-Ott KM, Hsu RK, Tio MC, Sarvode Mothi S, Singh H, Schrag D, Jhaveri KD, Reynolds KL, Cortazar FB, Leaf DE, ICPi-AKI Consortium Investigators. PMID: 34625513; PMCID: PMC8496384.
      View in: PubMed   Mentions: 60     Fields:    Translation:Humans
    4. Evaluating predictors of renal injury with sorafenib in hepatocellular carcinoma: A multi-ethnic cohort study. Journal of Onco-Nephrology. 2021; 5(2):89-95. Natsuhara KH, Zhang L, Carlos CA, Borno HT. View Publication.
    5. Predialysis fluid overload and gait speed: a repeated measures analysis among patients on chronic dialysis. Nephrol Dial Transplant. 2020 06 01; 35(6):1027-1031. Carlos C, Grimes B, Segal M, Johansen K. PMID: 31886859; PMCID: PMC7282826.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    6. Acute Kidney Injury with Immune Checkpoint Inhibitors: A Push beyond Case Reports. Clin J Am Soc Nephrol. 2019 12 06; 14(12):1679-1681. Carlos CA, Hsu RK. PMID: 31672795; PMCID: PMC6895476.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Colon Cancer Screening among Patients Receiving Dialysis in the United States: Are We Choosing Wisely? J Am Soc Nephrol. 2017 Aug; 28(8):2521-2528. Carlos CA, McCulloch CE, Hsu CY, Grimes B, Pavkov ME, Burrows NR, Shahinian VB, Saran R, Powe NR, Johansen KL, Centers for Disease Control and Prevention Chronic Kidney Disease Surveillance Team. PMID: 28336719; PMCID: PMC5533234.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    Christopher's Networks
    Concepts (28)
    Derived automatically from this person's publications.
    _
    Co-Authors (7)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _